Towards the end of 2019 Kagenova applied to StoryFutures R&D On Demand to test and quantify the effect of using copernic360 to reduce cyber motion sickness in virtual reality (VR).

As part of this programme Dr Elisa Ferre, a world-leading expert in vestibular neuroscience at the Department of Psychology at Royal Holloway University, and her team investigated the effectiveness of copernic360 in reducing cyber motion sickness. Fortunately the experimental trials were completed just before lockdown and results are now in!

The study showed copernic360 significantly reduces nausea compared to standard VR.

According to the results of the Simulator Sickness Questionnaire devised by Kennedy et al (2009) – the standard test for motion sickness – 92% of participants found copernic360 improved their experience in some way. An average reduction in nausea of 33% was observed across participants of the study when using copernic360, at 98% statistical significance.

“The results confirmed a very effective reduction in cybersickness [when using copernic360].” — Dr Ferre.

By bringing 6DOF motion to 360° VR experiences we knew conceptually that copernic360 would reduce cyber motion sickness. But it’s fantastic to see independent scientific evidence validating this.

The full case study can be found on StoryFutures website. An academic paper on the study is in preparation, so watch this space for further details!

If you’re interested in copernic360, please get in touch.